These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 548939)

  • 1. In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.
    Levison ME; Santoro J; Agarwal BN
    Postgrad Med J; 1979; 55 Suppl 4():12-6. PubMed ID: 548939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and sputum levels of cefaclor.
    Simon C; Gatzemeier U
    Postgrad Med J; 1979; 55 Suppl 4():30-4. PubMed ID: 548940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cefaclor.
    Derry JE
    Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro microbiological activity and stability of cefaclor.
    Gillett AP; Andrews JM; Wise R
    Postgrad Med J; 1979; 55 Suppl 4():9-11. PubMed ID: 44910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Larsson P; Lincoln K; Lind L; Sandberg T
    Scand J Infect Dis; 1988; 20(4):421-4. PubMed ID: 3057617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of cefaclor in subjects with normal renal function and in uraemic patients (author's transl)].
    Leroy A; Humbert G; Fillastre JP
    Therapie; 1981; 36(5):533-40. PubMed ID: 7323991
    [No Abstract]   [Full Text] [Related]  

  • 8. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Infection; 1979; 7 Suppl 6():557-61. PubMed ID: 45088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin.
    Welling PG; Dean S; Selen A; Kendall MJ; Wise R
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):397-400. PubMed ID: 500261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory studies with cefaclor: efficacy in skin and soft tissue infections.
    Dillon HC; Gray BM; Ware JC
    Postgrad Med J; 1979; 55 Suppl 4():77-81. PubMed ID: 548944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefaclor in patients with stable renal impairment, and patients undergoing haemodialysis.
    Gartenberg G; Meyers BR; Hirschmann SZ; Srulevitch E
    J Antimicrob Chemother; 1979 Jul; 5(4):465-70. PubMed ID: 489494
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysis.
    Spyker DA; Gober LL; Scheld WM; Sande MA; Bolton WK
    Antimicrob Agents Chemother; 1982 Feb; 21(2):278-81. PubMed ID: 7073265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of theophylline during co-treatment with cefaclor.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Hempenius J
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):88-92. PubMed ID: 3957498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bactericidal activity of amoxicillin and cefaclor in an "in vitro" kinetic model (author's transl)].
    Pothier P; Kazmierczak A; Siebor E; Gaillard MC; Pechinot A
    Ann Microbiol (Paris); 1981; 132(3):293-306. PubMed ID: 7027869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.
    Santoro J; Levison ME
    Antimicrob Agents Chemother; 1977 Sep; 12(3):442-3. PubMed ID: 907337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)].
    Lode H; Stahlmann R; Dzwillo G; Koeppe P
    Arzneimittelforschung; 1980; 30(3):505-9. PubMed ID: 7387765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro activity of cefaclor (author's transl)].
    Knothe H
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two new oral cephalosporins.
    Med Lett Drugs Ther; 1979 Oct; 21(21):85-7. PubMed ID: 502965
    [No Abstract]   [Full Text] [Related]  

  • 20. No effect of cefaclor on theophylline pharmacokinetics.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Hempenius J
    Eur J Respir Dis; 1985 Jan; 66(1):47-9. PubMed ID: 3979475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.